News, Policy & Media

24May

Government response to report on Brexit and medicines, medical devices and substances of human origin

Command paper responding to the Health and Social Care Committee's report 'Brexit: medicines, medical devices and substances of human origin'.

Published 23 May 2018
From:
Department of Health and Social Care, Intellectual Property Office, Medicines and Healthcare products Regulatory Agency, Office for Life Sciences, and Department for Exiting the European Union
Documents

Brexit: medicines, medical devices and substances of human origin – government response to the Health and Social Care Committee's 4th report of session 2017 to 2019
 

Details
This command paper sets out the government’s response to the Health and Social Care Committee’s report following their inquiry into Brexit: medicines, medical devices and substances of human origin.

The committee published their report on 21 March 2018.

This response was prepared by the Department of Health and Social Care, in collaboration with other government departments and agencies including:

the Medicines and Healthcare products Regulatory Agency
the Office for Life Sciences
the Intellectual Property Office
the Department for Exiting the European Union
Published 23 May 2018

Related

This document sets out what recent developments, such as agreement on the terms of an implementation...

Read More >

The Department of Health is pleased to announce that the Procurement Transformation Programme (PTP) ...

Read More >

Ninth annual report analysing the updated 2017 dataset from the bioscience and health technologies d...

Read More >

The briefing sessions will last for about 90 minutes. In that time you will hear and be able to disc...

Read More >

Business Secretary Greg Clark and Health Secretary Jeremy Hunt announce a Sector Deal with the life ...

Read More >

Revenues generated from IVD sales in the UK grew ahead of inflation in 2016, although positive growt...

Read More >